KSI-102

N/A

Report date: 2025/06/03 15:46:05

Base Information

Drug NameKSI-102

Drug Alias NameKSI-102

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin-6 inhibitors

TargetsTumor necrosis factor αInterleukin-6

Therapy Area/IndicationsEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKodiak Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesKodiak Sciences Inc

Inactive CompaniesN/A

Active IndicationsEye Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A